Antimicrobial resistance of Enterococcus sp. isolated from the intestinal tract of patients from a University Hospital in Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 7, 2004, Pages 763-767

  Maschieto, Andresa ^a   Martinez, Roberto ^a   Palazzo, Izabel Cristina Vanzato ^a   Da Costa Darini, Ana Lúcia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobials; Brazil; Enterococci; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANC PROTEIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ENZYME SYNTHESIS; HUMAN; INTESTINE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; UNIVERSITY HOSPITAL;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ENTEROCOCCUS SP.;

EID: 14044256611     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000700018     Document Type: Article

References (29)

1. Biavasco F, Paladini C, Vignaroli C, Foglia G, Manso E, Varaldo PE 2001. Recovery from a single blood culture of two Enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility. Eur J Clin Microbiol Infect Dis 5: 309-314.
2. Camargo ILBC, Barth AL, Pilger K, Seligman BGS, Machado A, Darini ALC 2004. Enterococcus gallinarum carrying vanA gene cluster. First report in Brazil. Braz J Med Biol Res, in press.
3. Cereda RF, Gales AC, Silbert S, Jones RN, Sader HS 2002. Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil. Infect Control Hosp Epidemiol 23: 19-22.
4. Cereda RF, Pignatari AC, Hashimoto A, Sader H 1997. In vitro antimicrobial activity against enterococci isolated in a university hospital in São Paulo, Brazil. Braz J Infect Dis 1: 83-90.
5. Cereda RF, Sader HS, Jones RN, Sejas L, Machado AM, Zanatta YP, Rego STMS, Medeiros EAS 2001. Enterococcus faecalis resistant to vancomycin and teicoplanin (VanA phenotype) isolated from a bone marrow transplanted patient in Brazil. Braz J Infect Dis 5: 40-46.
6. Dargere S, Vergnaud M, Verdon R, Saloux E, LePagE O, Leclercq R, Bazin C 2002. Enterococcus gallinarum endocarditis occurring on native heart valves. J Clin Microbiol 40: 2308-2310.
7. Dutka-Malen S, Blaimont B, Wauters G, Courvalin P 1994. Emergence of high-level resistant Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother 34: 1675-1677.
8. Dukta-Malen S, Evers S, Courvalin P 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33: 24-27.
9. Eliopoulos GM 2003. Quinupristin-Dalfopristin and Linezolid: evidence and opinion. Clin Infect Dis 36: 473-481.
10. Facklam RR, Sahm DF, Teixeira ALM 1999. Enterococcus. In PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken (eds), Manual of Clinical Microbiology, 7th ed., American Society for Microbiology, Washington DC, p. 297-315.
11. Kühn I, Iversen A, Burman LG, Olsson-Liljequist B, Franklin A, Finn M, Aarestrup F, Seyfarth AM, Franklin A, Finn M, Blanch AR, Vilanova X, Taylor H, Caplin J, Moreno MA, Dominguez L, Herrero IA, Möllby R 2003. Comparison of enterococcal populations in animals, humans, and the environment - A European study. Inter J Food Microbiol 88: 133-145.
12. Leclercq R 1997. Enterococci acquire new kinds of resistance. Clin Infect Dis 24 (Suppl. 1): 80S-84S.
13. Liassine N, Frei R, Jan I, Auckenthaler R 1998. Characterization of glycopeptide-resistant enterococci from a Swiss Hospital. J Clin Microbiol 36: 1853-1858.
14. MacFaddin JF 2000. Biochemical Tests for Identification of Medical Bacteria, 3rd ed., Lippincot Williams & Wilkins, US, 912 pp.
15. Mondino SS, Castro AC, Mondino PJ, Carvalho MG, Silva KM, Teixeira LM 2003. Phenotypic and genotypic characterization of clinical and intestinal enterococci isolated from inpatients and outpatients in two Brazilian hospitals. Microb Drug Resist 9: 167-174.
16. Montecalvo MA, Lancestre H, Carraber M, Gedris C, Chung M, VanHorn K, Wormser GP 1995. Natural history of colonization with vancomycin resistant Enterococcus faecium. Infect Control Hosp Epidemiol 16: 680-685.
17. Mutnick AH, Biendenbach DJ, Jones RN 2003. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 46: 63-68.
18. NCCLS-National Committee for Clinical Laboratory Standards 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th ed., Wayne, PA.
19. Reid KC, Cockerill FR, Patel R 2001. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteriemia: a report of 20 cases. Clin Infect Dis 32: 1540-1546.
20. Reis AO, Cordeiro JC, Machado AM, Sader HS 2001. In vitro antimicrobial activity of Linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals. Braz J Infect Dis 5: 243-251.
21. Ruoff KL, Whiley RA, Beighton D 1999. Streptococcus. In PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken (eds), Manual of Clinical Microbiology, 7th ed., American Society for Microbiology, Washington DC, p. 283-296.
22. Schooneveldt JM, Marriott RK, Nimmo GR 2000. Detection of vanB determinant in Enterococcus gallinarum in Australia. J Clin Microbiol 38: 3902.
23. Schouten MA 1999. Vancomycin resistant enterococci. Prevalence in Europe. Clin Microbiol Infec 8 (Supp. 1): 136.
24. Takayama Y, Sunakawa K, Akahoshi T 2003. Meningitis caused by Enterococcus gallinarum in patients with ventriculoperitoneal shunts. J Infect Chemother 9: 348-350.
25. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K 1997. Clinical and epidemiologic significance of enterococci intrinsically resistant to vancomycin (possessing the VanC genotype). J Clin Microbiol 3: 3166-3170.
26. Udo EE, Al-Sweih N, Phillips AO, Chugh TD 2003. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 52: 163-168.
27. Zanella RC, Brandileone MCC, Bokermann S, Almeida SCG, Valdetaro F, Votório F, Moreira MFA, Villins M, Salomão R, Pignatari AC 2003. Phenotypic and genotypic characterization of VanA Enterococcus isolated during the first nosocomial outbreak in Brazil. Microb Drug Resist 9: 283-291.
28. Zanella RC, Valdetaro F, Lovgren M, Tyrrel GJ, Bokermann S, Almeida SCG, Vieira VSD, Brandileone MCC 1999. First confirmed case of a vancomycin-resistant Enterococcus faecium with Van A phenotype from Brazil: isolation from a meningitis case in São Paulo. Microb Drug Resist 5: 159-162.
29. Zouain MG, Araj GF 2001. Antimicrobial resistance of enterococci in Lebanon. Int J Antimicrob Agents 17: 209-213.